YARROW BIOSCIENCE, INC. Unrecognized Tax Benefits
YARROW BIOSCIENCE, INC. (YARW) had Unrecognized Tax Benefits of $2.45 million as of 2025-12-31, per its S-4/A filed 2026-06-03.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefits · last filed 2026-06-03
- 2025-12-31: Unrecognized Tax Benefits $2.45M.
- 2024-12-31: Unrecognized Tax Benefits $2.57M.
- 2023-12-31: Unrecognized Tax Benefits $2.46M.
- 2022-12-31: Unrecognized Tax Benefits $2.85M.
| Period end | Unrecognized Tax Benefits | Unrecognized Tax Benefits as first filed |
|---|---|---|
| 2025-12-31 | $2.45M S-4/A · filed 2026-06-03 | |
| 2024-12-31 | $2.57M S-4/A · filed 2026-06-03 | |
| 2023-12-31 | $2.46M S-4/A · filed 2026-06-03 | |
| 2022-12-31 | $2.85M 10-K · filed 2025-03-06 | |
| 2021-12-31 | $2.80M 10-K · filed 2024-03-01 | |
| 2020-12-31 | $3.08M 10-K · filed 2023-03-14 | |
| 2019-12-31 | $714.00K 10-K · filed 2022-03-17 | $2.35M 10-K · filed 2020-03-03 |
| 2018-12-31 | $890.00K 10-K · filed 2021-03-04 | $1.46M 10-K · filed 2019-02-28 |
| 2017-12-31 | $803.00K 10-K · filed 2020-03-03 | |
| 2016-12-31 | $229.00K 10-K · filed 2020-03-03 | |
| 2015-12-31 | $93.00K 10-K · filed 2019-02-28 | |
| 2014-12-31 | $73.00K 10-K · filed 2018-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |